Skip to main content
letter
. 2019 Dec;104(12):e566–e569. doi: 10.3324/haematol.2019.219253

Figure 2.

Figure 2.

Flow cytometric staining of CCR4 expression on malignant cells. PBMC from patient A1 were stained as described in Rowan et al.14: with a viability stain and antibodies specific for CD3, CD4, CD8, TCRVβ5.1 and with two different anti-CCR4 mAb clones. Cells were gated on live, single, CD3+CD8TCRVβ5.1+ lymphocytes based on fluorescence minus one controls.